What's frightening is that type-2 diabetes patients often already have heart problems, and a drug that's suppose to help improve their health is just leading to more and more problems. But while the manufacturer, GlaxoSmithKline, may not have to lose profits by pulling the drug from shelves, they do have to answer to several angry families who are suing over the death of a loved one.